000			02108cam a2200217 4500500
005			20251012013202.0
041			_afre
042			_adc
100	1	0	_aPioche, Mathieu _eauthor
700	1	0	_a Chenegros, Benjamin _eauthor
700	1	0	_a Lafeuille, Pierre _eauthor
700	1	0	_a Walter, Thomas _eauthor
700	1	0	_a Paoli, Capucine _eauthor
700	1	0	_a Rivory, Jérome _eauthor
245	0	0	_aTelehealth in gastroenterology: All systems go to dispel skepticism and shrink our carbon footprint!
260			_c2025.
500			_a17
520			_aTelehealth (or telemedicine), although recently popularized due to technological advancements, has existed since the 2000s and plays a crucial role in improving access to care, reducing infectious risks, and lowering environmental impact. Numerous studies show that the quality of care via telemedicine can be equal to or even better than in-person consultations, especially in fields like dermatology or palliative care. It is also beneficial for vulnerable patients, such as those with cognitive disorders, who are often less stressed when treated at home. Telemedicine reduces costs associated with travel and hospital infrastructure, while also being more inclusive, particularly for isolated patients. It applies to a wide range of specialties, including gastroenterology, oncology, and pediatrics, where it helps save time without compromising care quality. Telemedicine is also more environmentally friendly, reducing patient travel and thus lowering its carbon footprint. Additionally, tele-expertise enables doctors to consult other specialists remotely, thereby improving the safety and quality of medical decision-making. These services are reimbursed by the French public health insurance system, and the conditions for coverage have been relaxed in recent years, further supporting the growth of telemedicine.
786	0		_nHépato-Gastro & Oncologie Digestive | 32 | 3 | 2025-03-28 | p. 256-261 | 2115-3310
856	4	1	_uhttps://shs.cairn.info/journal-hepato-gastro-oncologie-digestive-2025-3-page-256?lang=en&redirect-ssocas=7080
999			_c1528650 _d1528650